Pharmabiz8h
Govt should roll out comprehensive National Cancer Care Policy with dedicated funding outlay: FICCI-EY Parthenon Report
Govt should roll out comprehensive National Cancer Care Policy with dedicated funding outlay: FICCI-EY Parthenon Report: Our ...
Pharmabiz14h
Oversimplification about integration of traditional & modern treatment systems creates confusion: Dr Kotecha
Oversimplification about integration of traditional & modern treatment systems creates confusion: Dr Kotecha: Peethaambaran ...
Pharmabiz4h
Oncoinvent announces positive interim results from phase 1/2a studies of Radspherin for treatment of peritoneal carcinomatosis
Oncoinvent announces positive interim results from phase 1/2a studies of Radspherin for treatment of peritoneal carcinomatosis: Oslo, Norway Tuesday, November 12, 2024, 18:00 Hrs ...
Pharmabiz50m
ViiV Healthcare deepens its commitment to under-served LGBTI communities, pledging $7.8million in new funding
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, has announced it is pledging $7.8 million to the ‘Fund our Futures’ campaign led by ...
Pharmabiz7h
EnteroBiotix reports positive results from phase 1b IMPuLCE study of EBX-102 in liver cirrhosis
EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics, announced positive results from its phase 1b IMPuLCE study ...
Pharmabiz4m
ALIGNMT AI & HFMA collaborate to offer AI governance micro-credentialing for healthcare professionals
ALIGNMT AI, a leading provider of software solutions for AI governance and compliance, announced a strategic collaboration with the Healthcare Financial Management Association (HFMA) to launch a ...
Pharmabiz35m
STEERLife & Callidus Research Laboratories forge strategic partnership to accelerate innovative drug development
STEERLife, a pioneer in pharmaceutical development technologies, and Callidus Research Laboratories, a formulation development services company with a wealth of experience in comprehensive ...
Pharmabiz1h
Neurizon Therapeutics receives positive opinion on orphan medicinal product designation for NUZ-001 in Europe
Neurizon Therapeutics Limited (Neurizon), a clinical-stage biotech company advancing treatments for neurodegenerative diseases, announced it has received notice of a positive opinion from the European ...
Pharmabiz9h
Tectonic Therapeutic to present positive phase 1a results of TX45, a long-acting, Fc-relaxin fusion protein at AHA 2024
Tectonic Therapeutic to present positive phase 1a results of TX45, a long-acting, Fc-relaxin fusion protein at AHA 2024: Watertown, Massachusetts Tuesday, November 12, 2024, 13:00 ...
Pharmabiz10h
Healthium and HSSC ink MoU to enhance certification in skill development for Indian healthcare
Healthium and HSSC ink MoU to enhance certification in skill development for Indian healthcare: Our Bureau, Bengaluru Tuesday, November 12, 2024, 12:15 Hrs [IST] Healthium Medtech ...
Pharmabiz8h
GE HealthCare, RadNet collaborate to transform imaging systems and accelerate the adoption of AI with SmartTechnology
Chicago, Illinois Tuesday, November 12, 2024, 14:00 Hrs [IST] ...
Pharmabiz12h
Relief Therapeutics announces positive final results of RLF-TD011 trial in epidermolysis bullosa
Relief Therapeutics announces positive final results of RLF-TD011 trial in epidermolysis bullosa: Geneva Tuesday, November 12, 2024, 10:00 Hrs [IST] Relief Therapeutics Holding SA ...